• Carrying out phase I clinical trials from first-in-man until proof-of-concept, with interlinking between healthy trial participants and early clinical patient trials.
• Complete phase I trial surroundings with a highly experienced core team equipped with state-of-the-art technology.
• Experience in QTc trials (muse infrastructure is on-site)
• Data management and compilation of reports
• Integrated research plans for the same medication permit interconnection between phase I and phase II-II trials, resulting in shorter timelines for authorisation/licensing, thus creating a combination of early clinical research and late stage development.